nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—SLC22A4—Crohn's disease	0.456	0.571	CbGaD
Desipramine—SLC22A5—Crohn's disease	0.342	0.429	CbGaD
Desipramine—ORM1—bile—Crohn's disease	0.00619	0.126	CbGeAlD
Desipramine—CHRM3—muscle of abdomen—Crohn's disease	0.00567	0.116	CbGeAlD
Desipramine—HTR2A—enteric nervous system—Crohn's disease	0.00531	0.108	CbGeAlD
Desipramine—Drug fever—Mercaptopurine—Crohn's disease	0.00415	0.0894	CcSEcCtD
Desipramine—HTR2A—myenteric nerve plexus—Crohn's disease	0.00403	0.0822	CbGeAlD
Desipramine—Drug fever—Mesalazine—Crohn's disease	0.00225	0.0485	CcSEcCtD
Desipramine—SMPD1—skin of body—Crohn's disease	0.00173	0.0352	CbGeAlD
Desipramine—ORM1—gall bladder—Crohn's disease	0.00172	0.0351	CbGeAlD
Desipramine—Tongue discolouration—Mesalazine—Crohn's disease	0.00156	0.0335	CcSEcCtD
Desipramine—SMPD1—lymphoid tissue—Crohn's disease	0.0014	0.0285	CbGeAlD
Desipramine—SMPD1—digestive system—Crohn's disease	0.00138	0.0282	CbGeAlD
Desipramine—SLC22A3—mouth—Crohn's disease	0.00134	0.0273	CbGeAlD
Desipramine—CYP2C18—mammalian vulva—Crohn's disease	0.00128	0.0261	CbGeAlD
Desipramine—CHRM5—epithelium—Crohn's disease	0.00121	0.0247	CbGeAlD
Desipramine—CHRM5—skin of body—Crohn's disease	0.00115	0.0234	CbGeAlD
Desipramine—CYP2C18—digestive system—Crohn's disease	0.00112	0.0229	CbGeAlD
Desipramine—Abdominal cramps—Mesalazine—Crohn's disease	0.00111	0.024	CcSEcCtD
Desipramine—Withdrawal symptom—Prednisone—Crohn's disease	0.00097	0.0209	CcSEcCtD
Desipramine—Intraocular pressure increased—Prednisone—Crohn's disease	0.000905	0.0195	CcSEcCtD
Desipramine—SLC22A2—digestive system—Crohn's disease	0.000877	0.0179	CbGeAlD
Desipramine—Drug withdrawal syndrome—Prednisone—Crohn's disease	0.000812	0.0175	CcSEcCtD
Desipramine—SMPD1—lymph node—Crohn's disease	0.000789	0.0161	CbGeAlD
Desipramine—Stomatitis—Mercaptopurine—Crohn's disease	0.000756	0.0163	CcSEcCtD
Desipramine—Phosphatase alkaline increased—Mesalazine—Crohn's disease	0.000752	0.0162	CcSEcCtD
Desipramine—SLC22A3—smooth muscle tissue—Crohn's disease	0.00075	0.0153	CbGeAlD
Desipramine—SLC22A3—mammalian vulva—Crohn's disease	0.000675	0.0138	CbGeAlD
Desipramine—CHRM3—smooth muscle tissue—Crohn's disease	0.00065	0.0133	CbGeAlD
Desipramine—SLC22A4—digestive system—Crohn's disease	0.00065	0.0133	CbGeAlD
Desipramine—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.000628	0.0135	CcSEcCtD
Desipramine—Alopecia—Mercaptopurine—Crohn's disease	0.000615	0.0132	CcSEcCtD
Desipramine—Disorientation—Mesalazine—Crohn's disease	0.00061	0.0131	CcSEcCtD
Desipramine—Libido decreased—Mesalazine—Crohn's disease	0.000589	0.0127	CcSEcCtD
Desipramine—SLC6A4—digestive system—Crohn's disease	0.000576	0.0118	CbGeAlD
Desipramine—Delusion—Prednisone—Crohn's disease	0.000562	0.0121	CcSEcCtD
Desipramine—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.000542	0.0117	CcSEcCtD
Desipramine—SLC22A5—skin of body—Crohn's disease	0.000538	0.011	CbGeAlD
Desipramine—CHRM3—digestive system—Crohn's disease	0.000514	0.0105	CbGeAlD
Desipramine—Liver function test abnormal—Mesalazine—Crohn's disease	0.000504	0.0109	CcSEcCtD
Desipramine—Oedema—Mercaptopurine—Crohn's disease	0.000495	0.0106	CcSEcCtD
Desipramine—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000484	0.0104	CcSEcCtD
Desipramine—Petechiae—Prednisone—Crohn's disease	0.000484	0.0104	CcSEcCtD
Desipramine—HRH1—epithelium—Crohn's disease	0.00048	0.0098	CbGeAlD
Desipramine—CYP2C19—digestive system—Crohn's disease	0.000477	0.00975	CbGeAlD
Desipramine—Anorexia—Mercaptopurine—Crohn's disease	0.000471	0.0102	CcSEcCtD
Desipramine—Eosinophilia—Mesalazine—Crohn's disease	0.000467	0.0101	CcSEcCtD
Desipramine—CYP2B6—skin of body—Crohn's disease	0.000467	0.00954	CbGeAlD
Desipramine—HRH1—smooth muscle tissue—Crohn's disease	0.000462	0.00944	CbGeAlD
Desipramine—Pollakiuria—Mesalazine—Crohn's disease	0.000436	0.00939	CcSEcCtD
Desipramine—Agranulocytosis—Azathioprine—Crohn's disease	0.000431	0.00928	CcSEcCtD
Desipramine—SLC22A5—digestive system—Crohn's disease	0.00043	0.00879	CbGeAlD
Desipramine—Decreased appetite—Mercaptopurine—Crohn's disease	0.00043	0.00926	CcSEcCtD
Desipramine—Weight increased—Mesalazine—Crohn's disease	0.00043	0.00925	CcSEcCtD
Desipramine—Depression—Mesalazine—Crohn's disease	0.00042	0.00904	CcSEcCtD
Desipramine—HRH1—mammalian vulva—Crohn's disease	0.000416	0.0085	CbGeAlD
Desipramine—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000412	0.00888	CcSEcCtD
Desipramine—Stomatitis—Mesalazine—Crohn's disease	0.00041	0.00883	CcSEcCtD
Desipramine—Jaundice—Mesalazine—Crohn's disease	0.00041	0.00883	CcSEcCtD
Desipramine—HTR2A—epithelium—Crohn's disease	0.000401	0.00818	CbGeAlD
Desipramine—Agranulocytosis—Mesalazine—Crohn's disease	0.000393	0.00846	CcSEcCtD
Desipramine—Body temperature increased—Mercaptopurine—Crohn's disease	0.000391	0.00842	CcSEcCtD
Desipramine—CYP1A2—digestive system—Crohn's disease	0.00039	0.00796	CbGeAlD
Desipramine—ORM1—lymph node—Crohn's disease	0.000386	0.00788	CbGeAlD
Desipramine—HTR2A—smooth muscle tissue—Crohn's disease	0.000386	0.00788	CbGeAlD
Desipramine—CYP2B6—lymphoid tissue—Crohn's disease	0.000378	0.00773	CbGeAlD
Desipramine—Hepatitis—Mesalazine—Crohn's disease	0.000378	0.00814	CcSEcCtD
Desipramine—CYP2B6—digestive system—Crohn's disease	0.000374	0.00763	CbGeAlD
Desipramine—SLC22A4—lymph node—Crohn's disease	0.000371	0.00758	CbGeAlD
Desipramine—Arrhythmia—Azathioprine—Crohn's disease	0.00037	0.00798	CcSEcCtD
Desipramine—Alopecia—Azathioprine—Crohn's disease	0.000366	0.00789	CcSEcCtD
Desipramine—HRH1—digestive system—Crohn's disease	0.000365	0.00745	CbGeAlD
Desipramine—CYP2E1—lymphoid tissue—Crohn's disease	0.000355	0.00725	CbGeAlD
Desipramine—Tinnitus—Mesalazine—Crohn's disease	0.000352	0.00758	CcSEcCtD
Desipramine—CYP2E1—digestive system—Crohn's disease	0.000351	0.00716	CbGeAlD
Desipramine—Hyperkinesia—Prednisone—Crohn's disease	0.000347	0.00748	CcSEcCtD
Desipramine—Diarrhoea—Mercaptopurine—Crohn's disease	0.000338	0.00729	CcSEcCtD
Desipramine—SLC22A3—lymph node—Crohn's disease	0.000338	0.0069	CbGeAlD
Desipramine—Ill-defined disorder—Azathioprine—Crohn's disease	0.000335	0.00721	CcSEcCtD
Desipramine—Alopecia—Mesalazine—Crohn's disease	0.000334	0.00719	CcSEcCtD
Desipramine—Malaise—Azathioprine—Crohn's disease	0.000326	0.00701	CcSEcCtD
Desipramine—Vascular purpura—Prednisone—Crohn's disease	0.000323	0.00695	CcSEcCtD
Desipramine—Dysgeusia—Mesalazine—Crohn's disease	0.000322	0.00693	CcSEcCtD
Desipramine—Vomiting—Mercaptopurine—Crohn's disease	0.000314	0.00677	CcSEcCtD
Desipramine—Rash—Mercaptopurine—Crohn's disease	0.000312	0.00671	CcSEcCtD
Desipramine—Dermatitis—Mercaptopurine—Crohn's disease	0.000312	0.00671	CcSEcCtD
Desipramine—Vision blurred—Mesalazine—Crohn's disease	0.00031	0.00667	CcSEcCtD
Desipramine—Tremor—Mesalazine—Crohn's disease	0.000308	0.00663	CcSEcCtD
Desipramine—Ill-defined disorder—Mesalazine—Crohn's disease	0.000305	0.00657	CcSEcCtD
Desipramine—HTR2A—digestive system—Crohn's disease	0.000305	0.00622	CbGeAlD
Desipramine—Discomfort—Azathioprine—Crohn's disease	0.000304	0.00654	CcSEcCtD
Desipramine—Purpura—Prednisone—Crohn's disease	0.0003	0.00646	CcSEcCtD
Desipramine—Malaise—Mesalazine—Crohn's disease	0.000297	0.00639	CcSEcCtD
Desipramine—Nausea—Mercaptopurine—Crohn's disease	0.000294	0.00633	CcSEcCtD
Desipramine—Palpitations—Mesalazine—Crohn's disease	0.000291	0.00626	CcSEcCtD
Desipramine—SLC6A2—lymph node—Crohn's disease	0.00029	0.00592	CbGeAlD
Desipramine—Thrombocytopenia—Azathioprine—Crohn's disease	0.000288	0.00621	CcSEcCtD
Desipramine—Hypertension—Mesalazine—Crohn's disease	0.000284	0.00611	CcSEcCtD
Desipramine—CYP3A4—digestive system—Crohn's disease	0.000282	0.00576	CbGeAlD
Desipramine—Psychotic disorder—Prednisone—Crohn's disease	0.000282	0.00608	CcSEcCtD
Desipramine—Anxiety—Mesalazine—Crohn's disease	0.000279	0.00601	CcSEcCtD
Desipramine—CYP2D6—digestive system—Crohn's disease	0.000278	0.00567	CbGeAlD
Desipramine—Discomfort—Mesalazine—Crohn's disease	0.000277	0.00596	CcSEcCtD
Desipramine—Hypotension—Azathioprine—Crohn's disease	0.000275	0.00593	CcSEcCtD
Desipramine—Dry mouth—Mesalazine—Crohn's disease	0.000274	0.0059	CcSEcCtD
Desipramine—Confusional state—Mesalazine—Crohn's disease	0.000271	0.00583	CcSEcCtD
Desipramine—Oedema—Mesalazine—Crohn's disease	0.000268	0.00578	CcSEcCtD
Desipramine—Thrombocytopenia—Mesalazine—Crohn's disease	0.000263	0.00566	CcSEcCtD
Desipramine—ABCB1—epithelium—Crohn's disease	0.000263	0.00536	CbGeAlD
Desipramine—Tachycardia—Mesalazine—Crohn's disease	0.000262	0.00564	CcSEcCtD
Desipramine—Anorexia—Mesalazine—Crohn's disease	0.000256	0.00551	CcSEcCtD
Desipramine—Hypotension—Mesalazine—Crohn's disease	0.000251	0.0054	CcSEcCtD
Desipramine—SLC22A5—lymph node—Crohn's disease	0.000246	0.00502	CbGeAlD
Desipramine—Feeling abnormal—Azathioprine—Crohn's disease	0.000243	0.00523	CcSEcCtD
Desipramine—Insomnia—Mesalazine—Crohn's disease	0.000243	0.00523	CcSEcCtD
Desipramine—Paraesthesia—Mesalazine—Crohn's disease	0.000241	0.00519	CcSEcCtD
Desipramine—Somnolence—Mesalazine—Crohn's disease	0.000239	0.00514	CcSEcCtD
Desipramine—Dyspepsia—Mesalazine—Crohn's disease	0.000236	0.00509	CcSEcCtD
Desipramine—Decreased appetite—Mesalazine—Crohn's disease	0.000233	0.00502	CcSEcCtD
Desipramine—Abdominal pain—Azathioprine—Crohn's disease	0.000233	0.00502	CcSEcCtD
Desipramine—Body temperature increased—Azathioprine—Crohn's disease	0.000233	0.00502	CcSEcCtD
Desipramine—Fatigue—Mesalazine—Crohn's disease	0.000231	0.00498	CcSEcCtD
Desipramine—Erectile dysfunction—Prednisone—Crohn's disease	0.00023	0.00495	CcSEcCtD
Desipramine—Constipation—Mesalazine—Crohn's disease	0.00023	0.00494	CcSEcCtD
Desipramine—ABCB1—mammalian vulva—Crohn's disease	0.000228	0.00465	CbGeAlD
Desipramine—Weight increased—Prednisone—Crohn's disease	0.000227	0.00489	CcSEcCtD
Desipramine—Depression—Prednisone—Crohn's disease	0.000222	0.00478	CcSEcCtD
Desipramine—Feeling abnormal—Mesalazine—Crohn's disease	0.000221	0.00476	CcSEcCtD
Desipramine—Acute coronary syndrome—Prednisone—Crohn's disease	0.000219	0.00473	CcSEcCtD
Desipramine—Myocardial infarction—Prednisone—Crohn's disease	0.000218	0.0047	CcSEcCtD
Desipramine—Neuropathy peripheral—Prednisone—Crohn's disease	0.000218	0.0047	CcSEcCtD
Desipramine—Urticaria—Mesalazine—Crohn's disease	0.000213	0.00459	CcSEcCtD
Desipramine—Abdominal pain—Mesalazine—Crohn's disease	0.000212	0.00457	CcSEcCtD
Desipramine—Body temperature increased—Mesalazine—Crohn's disease	0.000212	0.00457	CcSEcCtD
Desipramine—HRH1—lymph node—Crohn's disease	0.000208	0.00426	CbGeAlD
Desipramine—ABCB1—lymphoid tissue—Crohn's disease	0.000202	0.00413	CbGeAlD
Desipramine—Diarrhoea—Azathioprine—Crohn's disease	0.000202	0.00434	CcSEcCtD
Desipramine—ABCB1—digestive system—Crohn's disease	0.0002	0.00408	CbGeAlD
Desipramine—Hallucination—Prednisone—Crohn's disease	0.000199	0.00428	CcSEcCtD
Desipramine—Dizziness—Azathioprine—Crohn's disease	0.000195	0.0042	CcSEcCtD
Desipramine—Asthenia—Mesalazine—Crohn's disease	0.000193	0.00415	CcSEcCtD
Desipramine—Pruritus—Mesalazine—Crohn's disease	0.00019	0.00409	CcSEcCtD
Desipramine—Vomiting—Azathioprine—Crohn's disease	0.000187	0.00403	CcSEcCtD
Desipramine—Rash—Azathioprine—Crohn's disease	0.000186	0.004	CcSEcCtD
Desipramine—Dermatitis—Azathioprine—Crohn's disease	0.000186	0.004	CcSEcCtD
Desipramine—Flushing—Prednisone—Crohn's disease	0.000185	0.00399	CcSEcCtD
Desipramine—Headache—Azathioprine—Crohn's disease	0.000185	0.00397	CcSEcCtD
Desipramine—Imipramine—SLC22A4—Crohn's disease	0.000184	0.338	CrCbGaD
Desipramine—Diarrhoea—Mesalazine—Crohn's disease	0.000184	0.00395	CcSEcCtD
Desipramine—Arrhythmia—Prednisone—Crohn's disease	0.000179	0.00385	CcSEcCtD
Desipramine—Dizziness—Mesalazine—Crohn's disease	0.000177	0.00382	CcSEcCtD
Desipramine—Alopecia—Prednisone—Crohn's disease	0.000177	0.0038	CcSEcCtD
Desipramine—Nausea—Azathioprine—Crohn's disease	0.000175	0.00377	CcSEcCtD
Desipramine—Vomiting—Mesalazine—Crohn's disease	0.000171	0.00367	CcSEcCtD
Desipramine—Rash—Mesalazine—Crohn's disease	0.000169	0.00364	CcSEcCtD
Desipramine—Dermatitis—Mesalazine—Crohn's disease	0.000169	0.00364	CcSEcCtD
Desipramine—Headache—Mesalazine—Crohn's disease	0.000168	0.00362	CcSEcCtD
Desipramine—Vision blurred—Prednisone—Crohn's disease	0.000164	0.00353	CcSEcCtD
Desipramine—Ill-defined disorder—Prednisone—Crohn's disease	0.000161	0.00348	CcSEcCtD
Desipramine—Agitation—Prednisone—Crohn's disease	0.00016	0.00344	CcSEcCtD
Desipramine—Nausea—Mesalazine—Crohn's disease	0.000159	0.00343	CcSEcCtD
Desipramine—Malaise—Prednisone—Crohn's disease	0.000157	0.00338	CcSEcCtD
Desipramine—Convulsion—Prednisone—Crohn's disease	0.000151	0.00325	CcSEcCtD
Desipramine—Hypertension—Prednisone—Crohn's disease	0.00015	0.00323	CcSEcCtD
Desipramine—Anxiety—Prednisone—Crohn's disease	0.000148	0.00318	CcSEcCtD
Desipramine—Discomfort—Prednisone—Crohn's disease	0.000146	0.00315	CcSEcCtD
Desipramine—Oedema—Prednisone—Crohn's disease	0.000142	0.00306	CcSEcCtD
Desipramine—Tachycardia—Prednisone—Crohn's disease	0.000139	0.00298	CcSEcCtD
Desipramine—Anorexia—Prednisone—Crohn's disease	0.000135	0.00291	CcSEcCtD
Desipramine—Insomnia—Prednisone—Crohn's disease	0.000128	0.00277	CcSEcCtD
Desipramine—Paraesthesia—Prednisone—Crohn's disease	0.000128	0.00275	CcSEcCtD
Desipramine—Dyspepsia—Prednisone—Crohn's disease	0.000125	0.00269	CcSEcCtD
Desipramine—Decreased appetite—Prednisone—Crohn's disease	0.000123	0.00266	CcSEcCtD
Desipramine—Fatigue—Prednisone—Crohn's disease	0.000122	0.00264	CcSEcCtD
Desipramine—Constipation—Prednisone—Crohn's disease	0.000121	0.00261	CcSEcCtD
Desipramine—Feeling abnormal—Prednisone—Crohn's disease	0.000117	0.00252	CcSEcCtD
Desipramine—ABCB1—lymph node—Crohn's disease	0.000114	0.00233	CbGeAlD
Desipramine—Urticaria—Prednisone—Crohn's disease	0.000113	0.00243	CcSEcCtD
Desipramine—Abdominal pain—Prednisone—Crohn's disease	0.000112	0.00242	CcSEcCtD
Desipramine—Body temperature increased—Prednisone—Crohn's disease	0.000112	0.00242	CcSEcCtD
Desipramine—Asthenia—Prednisone—Crohn's disease	0.000102	0.00219	CcSEcCtD
Desipramine—Pruritus—Prednisone—Crohn's disease	0.0001	0.00216	CcSEcCtD
Desipramine—Oxcarbazepine—ALB—Crohn's disease	9.8e-05	0.18	CrCbGaD
Desipramine—Diarrhoea—Prednisone—Crohn's disease	9.72e-05	0.00209	CcSEcCtD
Desipramine—Dizziness—Prednisone—Crohn's disease	9.39e-05	0.00202	CcSEcCtD
Desipramine—Vomiting—Prednisone—Crohn's disease	9.03e-05	0.00194	CcSEcCtD
Desipramine—Rash—Prednisone—Crohn's disease	8.95e-05	0.00193	CcSEcCtD
Desipramine—Dermatitis—Prednisone—Crohn's disease	8.94e-05	0.00193	CcSEcCtD
Desipramine—Headache—Prednisone—Crohn's disease	8.9e-05	0.00192	CcSEcCtD
Desipramine—Nausea—Prednisone—Crohn's disease	8.43e-05	0.00182	CcSEcCtD
Desipramine—Acepromazine—ALB—Crohn's disease	7.41e-05	0.136	CrCbGaD
Desipramine—Clomipramine—ALB—Crohn's disease	5.63e-05	0.103	CrCbGaD
Desipramine—Nortriptyline—ALB—Crohn's disease	5.5e-05	0.101	CrCbGaD
Desipramine—Chlorpromazine—ALB—Crohn's disease	3.86e-05	0.0709	CrCbGaD
Desipramine—Amitriptyline—ALB—Crohn's disease	3.82e-05	0.0701	CrCbGaD
Desipramine—ABCB1—Metabolism—GCKR—Crohn's disease	1.16e-05	0.000109	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—RBX1—Crohn's disease	1.15e-05	0.000109	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PTGER4—Crohn's disease	1.15e-05	0.000109	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—RIPK2—Crohn's disease	1.15e-05	0.000108	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—IL2RA—Crohn's disease	1.15e-05	0.000108	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—RBX1—Crohn's disease	1.14e-05	0.000108	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL3—Crohn's disease	1.14e-05	0.000108	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—IL2RA—Crohn's disease	1.14e-05	0.000108	CbGpPWpGaD
Desipramine—CHRM4—GPCR downstream signaling—CXCL8—Crohn's disease	1.14e-05	0.000108	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—RIPK2—Crohn's disease	1.14e-05	0.000107	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—TYK2—Crohn's disease	1.14e-05	0.000107	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—IL2RA—Crohn's disease	1.14e-05	0.000107	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—JAK2—Crohn's disease	1.14e-05	0.000107	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—IL2RA—Crohn's disease	1.14e-05	0.000107	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PTGER4—Crohn's disease	1.13e-05	0.000107	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PTGER4—Crohn's disease	1.13e-05	0.000107	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—RASGRP1—Crohn's disease	1.13e-05	0.000107	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—GPX4—Crohn's disease	1.13e-05	0.000106	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PTGER4—Crohn's disease	1.13e-05	0.000106	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—IL2RA—Crohn's disease	1.12e-05	0.000106	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PTGER4—Crohn's disease	1.12e-05	0.000106	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL3—Crohn's disease	1.12e-05	0.000105	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PTGER4—Crohn's disease	1.11e-05	0.000105	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL3—Crohn's disease	1.11e-05	0.000105	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—RASGRP1—Crohn's disease	1.11e-05	0.000104	CbGpPWpGaD
Desipramine—CHRM5—GPCR downstream signaling—CXCL8—Crohn's disease	1.09e-05	0.000103	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—GCKR—Crohn's disease	1.09e-05	0.000103	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—JAK2—Crohn's disease	1.09e-05	0.000102	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—RASGRP1—Crohn's disease	1.08e-05	0.000102	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—SMAD3—Crohn's disease	1.08e-05	0.000102	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—RASGRP1—Crohn's disease	1.08e-05	0.000101	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—ALB—Crohn's disease	1.07e-05	0.000101	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	1.04e-05	9.78e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—CXCL8—Crohn's disease	1.04e-05	9.77e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—SMAD3—Crohn's disease	1.03e-05	9.73e-05	CbGpPWpGaD
Desipramine—ADRB1—GPCR downstream signaling—JAK2—Crohn's disease	1.03e-05	9.67e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—SOCS1—Crohn's disease	1.02e-05	9.65e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	1.02e-05	9.62e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—FADS1—Crohn's disease	1.02e-05	9.62e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—UBE2D1—Crohn's disease	1.02e-05	9.6e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—UBE2D1—Crohn's disease	1.02e-05	9.57e-05	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—ALB—Crohn's disease	1.01e-05	9.56e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—UBE2D1—Crohn's disease	1.01e-05	9.54e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.01e-05	9.53e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—RIPK2—Crohn's disease	1.01e-05	9.48e-05	CbGpPWpGaD
Desipramine—ADRB2—GPCR downstream signaling—JAK2—Crohn's disease	1e-05	9.46e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—UBE2D1—Crohn's disease	1e-05	9.45e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—SOCS1—Crohn's disease	1e-05	9.44e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IL2RA—Crohn's disease	9.98e-06	9.4e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—CXCL8—Crohn's disease	9.92e-06	9.35e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	9.9e-06	9.33e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—RIPK2—Crohn's disease	9.88e-06	9.31e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—RIPK2—Crohn's disease	9.85e-06	9.28e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—RIPK2—Crohn's disease	9.82e-06	9.25e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL3—Crohn's disease	9.82e-06	9.25e-05	CbGpPWpGaD
Desipramine—HTR1A—GPCR downstream signaling—JAK2—Crohn's disease	9.81e-06	9.25e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—SOCS1—Crohn's disease	9.8e-06	9.23e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—TYK2—Crohn's disease	9.77e-06	9.2e-05	CbGpPWpGaD
Desipramine—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	9.76e-06	9.2e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	9.75e-06	9.18e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	9.72e-06	9.16e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL3—Crohn's disease	9.66e-06	9.1e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL3—Crohn's disease	9.64e-06	9.08e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL3—Crohn's disease	9.61e-06	9.05e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL3—Crohn's disease	9.58e-06	9.02e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GPX4—Crohn's disease	9.56e-06	9.01e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IL2RA—Crohn's disease	9.56e-06	9.01e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—TYK2—Crohn's disease	9.55e-06	9e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	9.49e-06	8.95e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL3—Crohn's disease	9.48e-06	8.94e-05	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—PTGS2—Crohn's disease	9.4e-06	8.85e-05	CbGpPWpGaD
Desipramine—ADRB1—GPCR downstream signaling—CXCL8—Crohn's disease	9.36e-06	8.82e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	9.34e-06	8.8e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—TYK2—Crohn's disease	9.34e-06	8.8e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	9.32e-06	8.78e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—JAK2—Crohn's disease	9.32e-06	8.78e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	9.29e-06	8.76e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	9.29e-06	8.75e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—RASGRP1—Crohn's disease	9.26e-06	8.73e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GCKR—Crohn's disease	9.23e-06	8.7e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	9.17e-06	8.64e-05	CbGpPWpGaD
Desipramine—ADRB2—GPCR downstream signaling—CXCL8—Crohn's disease	9.16e-06	8.63e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—JAK2—Crohn's disease	9.11e-06	8.59e-05	CbGpPWpGaD
Desipramine—HTR1A—GPCR downstream signaling—CXCL8—Crohn's disease	8.96e-06	8.44e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—JAK2—Crohn's disease	8.91e-06	8.4e-05	CbGpPWpGaD
Desipramine—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	8.91e-06	8.39e-05	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—PTGS2—Crohn's disease	8.88e-06	8.37e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	8.86e-06	8.35e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—SMAD3—Crohn's disease	8.84e-06	8.33e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—SMAD3—Crohn's disease	8.65e-06	8.15e-05	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	8.62e-06	8.12e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—SOCS1—Crohn's disease	8.6e-06	8.1e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—CXCL8—Crohn's disease	8.5e-06	8.01e-05	CbGpPWpGaD
Desipramine—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	8.48e-06	7.99e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	8.47e-06	7.98e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	8.46e-06	7.97e-05	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	8.46e-06	7.97e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	8.46e-06	7.97e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—SOCS1—Crohn's disease	8.44e-06	7.96e-05	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	8.43e-06	7.94e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	8.42e-06	7.93e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	8.41e-06	7.93e-05	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	8.4e-06	7.92e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	8.39e-06	7.91e-05	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	8.32e-06	7.84e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—CXCL8—Crohn's disease	8.32e-06	7.84e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	8.31e-06	7.83e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—TYK2—Crohn's disease	8.2e-06	7.73e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IL2RA—Crohn's disease	8.19e-06	7.71e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	8.13e-06	7.66e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	8.09e-06	7.62e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	8.07e-06	7.6e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—TYK2—Crohn's disease	8.05e-06	7.59e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	8.03e-06	7.56e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL2RA—Crohn's disease	8.01e-06	7.55e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	8e-06	7.54e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	7.92e-06	7.47e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—FADS1—Crohn's disease	7.88e-06	7.42e-05	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	7.86e-06	7.41e-05	CbGpPWpGaD
Desipramine—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	7.86e-06	7.4e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	7.83e-06	7.38e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—JAK2—Crohn's disease	7.82e-06	7.37e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	7.79e-06	7.34e-05	CbGpPWpGaD
Desipramine—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	7.74e-06	7.29e-05	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	7.72e-06	7.27e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	7.7e-06	7.25e-05	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	7.7e-06	7.25e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—JAK2—Crohn's disease	7.68e-06	7.24e-05	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	7.67e-06	7.23e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	7.66e-06	7.21e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	7.63e-06	7.19e-05	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	7.6e-06	7.16e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	7.56e-06	7.12e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—SMAD3—Crohn's disease	7.43e-06	7e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	7.41e-06	6.98e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GPX4—Crohn's disease	7.38e-06	6.95e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	7.31e-06	6.88e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—SMAD3—Crohn's disease	7.29e-06	6.87e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	7.27e-06	6.85e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	7.24e-06	6.83e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	7.17e-06	6.76e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	7.14e-06	6.73e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GCKR—Crohn's disease	7.12e-06	6.71e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TYK2—Crohn's disease	7.03e-06	6.63e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	7.03e-06	6.62e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	7.01e-06	6.61e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	6.99e-06	6.58e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	6.97e-06	6.56e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	6.9e-06	6.5e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL2RA—Crohn's disease	6.88e-06	6.48e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	6.77e-06	6.37e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL2RA—Crohn's disease	6.75e-06	6.36e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—ALB—Crohn's disease	6.74e-06	6.35e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TYK2—Crohn's disease	6.73e-06	6.34e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	6.73e-06	6.34e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—JAK2—Crohn's disease	6.71e-06	6.32e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	6.71e-06	6.32e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	6.64e-06	6.26e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.6e-06	6.22e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—JAK2—Crohn's disease	6.42e-06	6.05e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—ALB—Crohn's disease	6.28e-06	5.92e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—ALB—Crohn's disease	6.18e-06	5.83e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—CXCL8—Crohn's disease	6.12e-06	5.77e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PTGS2—Crohn's disease	5.89e-06	5.55e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—CXCL8—Crohn's disease	5.86e-06	5.52e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—IL6—Crohn's disease	5.82e-06	5.49e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—ALB—Crohn's disease	5.8e-06	5.47e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.77e-06	5.44e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TYK2—Crohn's disease	5.77e-06	5.44e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TYK2—Crohn's disease	5.64e-06	5.32e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—IL6—Crohn's disease	5.58e-06	5.25e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TYK2—Crohn's disease	5.52e-06	5.2e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—JAK2—Crohn's disease	5.5e-06	5.19e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PTGS2—Crohn's disease	5.49e-06	5.18e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TYK2—Crohn's disease	5.49e-06	5.17e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PTGS2—Crohn's disease	5.41e-06	5.1e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—JAK2—Crohn's disease	5.38e-06	5.07e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—JAK2—Crohn's disease	5.26e-06	4.96e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—JAK2—Crohn's disease	5.24e-06	4.93e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PTGS2—Crohn's disease	5.07e-06	4.78e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CXCL8—Crohn's disease	5.02e-06	4.73e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—ALB—Crohn's disease	4.99e-06	4.7e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—STAT3—Crohn's disease	4.92e-06	4.64e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CXCL8—Crohn's disease	4.91e-06	4.63e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—ALB—Crohn's disease	4.89e-06	4.6e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TYK2—Crohn's disease	4.84e-06	4.56e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	4.8e-06	4.53e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	4.78e-06	4.5e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—IL6—Crohn's disease	4.78e-06	4.5e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TYK2—Crohn's disease	4.77e-06	4.49e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TYK2—Crohn's disease	4.76e-06	4.48e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TYK2—Crohn's disease	4.74e-06	4.47e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TYK2—Crohn's disease	4.73e-06	4.45e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—STAT3—Crohn's disease	4.72e-06	4.44e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TYK2—Crohn's disease	4.68e-06	4.41e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—IL6—Crohn's disease	4.67e-06	4.4e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—JAK2—Crohn's disease	4.62e-06	4.35e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—IL6—Crohn's disease	4.57e-06	4.3e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—JAK2—Crohn's disease	4.55e-06	4.28e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—IL6—Crohn's disease	4.54e-06	4.28e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—JAK2—Crohn's disease	4.54e-06	4.28e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—JAK2—Crohn's disease	4.52e-06	4.26e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—JAK2—Crohn's disease	4.51e-06	4.25e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—JAK2—Crohn's disease	4.46e-06	4.21e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PTGS2—Crohn's disease	4.37e-06	4.11e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PTGS2—Crohn's disease	4.28e-06	4.03e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CXCL8—Crohn's disease	4.22e-06	3.97e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	4.15e-06	3.91e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CXCL8—Crohn's disease	4.14e-06	3.9e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	4.13e-06	3.89e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	4.12e-06	3.88e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	4.08e-06	3.84e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—STAT3—Crohn's disease	4.04e-06	3.81e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—IL6—Crohn's disease	4.01e-06	3.78e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—STAT3—Crohn's disease	3.95e-06	3.72e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—IL6—Crohn's disease	3.95e-06	3.72e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—IL6—Crohn's disease	3.94e-06	3.71e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—IL6—Crohn's disease	3.93e-06	3.7e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—IL6—Crohn's disease	3.91e-06	3.69e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—IL6—Crohn's disease	3.88e-06	3.65e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—STAT3—Crohn's disease	3.86e-06	3.64e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—STAT3—Crohn's disease	3.84e-06	3.62e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—ALB—Crohn's disease	3.77e-06	3.55e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—ALB—Crohn's disease	3.68e-06	3.47e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—ALB—Crohn's disease	3.47e-06	3.27e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IL6—Crohn's disease	3.44e-06	3.24e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—STAT3—Crohn's disease	3.39e-06	3.2e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—STAT3—Crohn's disease	3.34e-06	3.14e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—STAT3—Crohn's disease	3.33e-06	3.14e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—STAT3—Crohn's disease	3.32e-06	3.13e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—STAT3—Crohn's disease	3.31e-06	3.12e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTGS2—Crohn's disease	3.3e-06	3.11e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IL6—Crohn's disease	3.29e-06	3.1e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—STAT3—Crohn's disease	3.28e-06	3.09e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTGS2—Crohn's disease	3.22e-06	3.03e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTGS2—Crohn's disease	3.03e-06	2.86e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—ALB—Crohn's disease	2.94e-06	2.77e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IL6—Crohn's disease	2.82e-06	2.66e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL6—Crohn's disease	2.76e-06	2.6e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL6—Crohn's disease	2.7e-06	2.54e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL6—Crohn's disease	2.68e-06	2.53e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTGS2—Crohn's disease	2.57e-06	2.42e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL6—Crohn's disease	2.37e-06	2.23e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL6—Crohn's disease	2.33e-06	2.2e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL6—Crohn's disease	2.33e-06	2.19e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL6—Crohn's disease	2.32e-06	2.18e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL6—Crohn's disease	2.31e-06	2.18e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL6—Crohn's disease	2.29e-06	2.16e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ALB—Crohn's disease	2.27e-06	2.14e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.98e-06	1.87e-05	CbGpPWpGaD
